Form 10-K SILICON LABORATORIES For: Dec 28
Exhibit 21
Subsidiaries of the Registrant
|
|
|
Organized Under Law Of |
|
Silicon Laboratories Australia Pty Ltd. |
Australia |
|
|
Silicon Laboratories Canada ULC |
|
Canada |
|
Shenzhen Silicon Laboratories Technology Co. Ltd. |
|
China |
|
Silicon Laboratories Denmark Aps |
|
Denmark |
|
Silicon Laboratories Finland Oy |
|
Finland |
|
Silicon Laboratories France SAS |
|
France |
|
Silicon Laboratories GmbH |
|
Germany |
|
Silicon Laboratories Asia Pacific, Limited |
|
Hong Kong |
|
Silicon Laboratories Hungary Korlátolt Felelősségű Társaság |
|
Hungary |
|
Silicon Laboratories Semiconductors India Private Limited |
|
India |
|
Silicon Laboratories Italy, S.r.l. |
|
Italy |
|
Silicon Laboratories Y.K. |
|
Japan |
|
Silicon Laboratories Norway AS |
|
Norway |
|
Silicon Laboratories International Pte. Ltd. |
|
Singapore |
|
Silicon Laboratories UK Limited |
|
United Kingdom |
|
Silicon Labs Spectra, Inc. |
|
State of California |
|
Zentri, Inc. |
|
State of Delaware |
|
Z‑Wave Alliance, LLC. |
|
State of Delaware |
|
Micrium LLC |
|
State of Florida |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S‑8 Nos. 333‑39528, 333‑45682, 333‑60794, 333‑83844, 333‑104771, 333‑112324, 333‑122845, 333‑131700, 333‑140862, 333‑149104, 333‑158938, 333‑195558, and 333‑219454) pertaining to the stock incentive and employee stock purchase plans of Silicon Laboratories Inc. of our reports dated January 29, 2020, with respect to the consolidated financial statements of Silicon Laboratories Inc., and the effectiveness of internal control over financial reporting of Silicon Laboratories Inc., included in this Annual Report (Form 10‑K) for the fiscal year ended December 28, 2019.
/s/ Ernst & Young LLP
Austin, Texas
January 29, 2020
Exhibit 31.1
Certification to the Securities and Exchange Commission
by Registrant’s Chief Executive Officer, as required by Section 302
of the Sarbanes‑Oxley Act of 2002
I, G. Tyson Tuttle, certify that:
1. I have reviewed this report on Form 10‑K of Silicon Laboratories Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a‑15(e) and 15d‑15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a‑15(f) and 15d‑15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: January 29, 2020 |
|
|
|
|
|
/s/ G. Tyson Tuttle |
|
|
G. Tyson Tuttle |
|
|
President and Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
Exhibit 31.2
Certification to the Securities and Exchange Commission
by Registrant’s Chief Financial Officer, as required by Section 302
of the Sarbanes‑Oxley Act of 2002
I, John C. Hollister, certify that:
1. I have reviewed this report on Form 10‑K of Silicon Laboratories Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a‑15(e) and 15d‑15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a‑15(f) and 15d‑15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date: January 29, 2020 |
|
|
|
|
|
/s/ John C. Hollister |
|
|
John C. Hollister. |
|
|
Senior Vice President and Chief Financial Officer |
|
|
(Principal Financial Officer) |
|
Exhibit 32.1
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes‑Oxley Act of 2002, each of the undersigned officers of Silicon Laboratories Inc. (the “Company”) hereby certify that:
(i) the accompanying Annual Report on Form 10‑K of the Company for the fiscal year ended December 28, 2019 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities Exchange Commission or its staff upon request.
Date: January 29, 2020
|
/s/ G. Tyson Tuttle |
|
|
G. Tyson Tuttle |
|
|
President and Chief Executive Officer |
|
|
|
|
|
|
|
|
/s/ John C. Hollister |
|
|
John C. Hollister |
|
|
Senior Vice President and Chief Financial Officer |
|
